1988
DOI: 10.1016/0169-4758(88)90163-9
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacology of ivermectin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

5
47
0
2

Year Published

1990
1990
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 59 publications
(54 citation statements)
references
References 14 publications
5
47
0
2
Order By: Relevance
“…There is much interest in the potential of ivermectin (IVM) as a microfilaricide for the treatment of onchocerciasis (Bennett, Williams & Dave, 1988), and mass trials against onchocerciasis are being implemented in 12 African and Central American countries. IVM has proven to be a very effective antiparasitic drug and many of the common gastrointestinal nematodes are highly susceptible to IVM at concentrations much lower than those at which other anthelmintics are effective.…”
Section: Introductionmentioning
confidence: 99%
“…There is much interest in the potential of ivermectin (IVM) as a microfilaricide for the treatment of onchocerciasis (Bennett, Williams & Dave, 1988), and mass trials against onchocerciasis are being implemented in 12 African and Central American countries. IVM has proven to be a very effective antiparasitic drug and many of the common gastrointestinal nematodes are highly susceptible to IVM at concentrations much lower than those at which other anthelmintics are effective.…”
Section: Introductionmentioning
confidence: 99%
“…In vitro, IVM effects on mf appear only at concentrations far above levels achieved during therapy for filariases (9). In the model nematode Caenorhabditis elegans and intestinal parasitic nematodes, IVM affects pharyngeal pumping and motor activity at concentrations 0.1 to 10 nM (10)(11)(12).…”
mentioning
confidence: 99%
“…Su gran tamaño molecular y el alto grado de unión a las proteínas del plasma limita su paso hacia el SNC a través de la BHE (Fisher y Mrozik 1992, Paul y Bajean 1993. Esta limitada distribución hacia el SNC parece ser el factor más importante en la diferenciación de la toxicidad selectiva hacia los invertebrados y de su amplio margen de seguridad para el huésped mamífero vertebrado (Campbell y Benz 1984, Bennet 1986). Sin embargo, algunos factores como el insuficiente desarrollo de la BHE en los recién nacidos o la acción de procesos febriles pueden determinar que se incremente el paso de moléculas de IVM hacia el SNC y logre concentraciones que sean capaces de actuar sobre las neuronas gabaergicas y ejercer alguna acción farmacológica.…”
Section: Residuos De Ivermectina En Predios Lecherosunclassified